TERT and nasopharyngeal carcinoma: In particular, it has been demonstrated that LMP-1 activates TERT in nasopharyngeal carcinoma cells through the AKT pathway [34]: in established LCLs, LMP-1 activates TERT at transcriptional level via the NF-κB and MAPK/ERK1/2 pathways [36].